Analyst Ratings for Ideaya Biosciences (IDYA)
IDYA Rating Summary
IDYA Price Target Summary
- Highest: $79.00 (JPMorgan)
- Lowest: $35.00 (Goldman Sachs)
- Average: $52.77
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$52.77 (+40.9%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
Avg. $ Target:
$52.77 (+40.9%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/7/2026 | UBS | Michael Yee | New Coverage | Buy (N/A) |
50.00 (N/A) |
34.94 (37.45) |
7.18% | Details |
| 11/24/2025 | Truist Securities » Updated 7/7/2026 |
Greg Renza | New Coverage | Buy (N/A) |
63.00 (65.00) |
33.99 (37.45) |
10.18% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
